{"@context":"https://schema.org","@type":"Legislation","name":"Maternal Health Pandemic Response Act of 2020","description":"

Maternal Health Pandemic Response Act of 2020

This bill addresses maternal health during the COVID-19 (i.e., coronavirus disease 2019) emergency by supporting data collection, development of COVID-19 therapeutics and workplace protections, and other activities.

Specifically, the Department of Health and Human Services must issue guidance for states and local health departments on collecting data on pregnancy and postpartum status in conjunction with COVID-19 tests. In addition, the bill provides funds for the Centers for Disease Control and Prevention (CDC) to expand particular maternal health surveillance programs. The CDC and the Centers for Medicare & Medicaid Services must also publish pregnancy and postpartum data related to COVID-19, and the CDC and the Indian Health Service must consult with tribes about collecting this data for tribal populations.

Additionally, the National Institutes of Health (NIH) and the Food and Drug Administration must collect information about the effects of COVID-19 therapeutics on pregnant and postpartum individuals. The NIH must also ensure that at least one vaccine will be suitable for that population and must support related research.

In addition, the Department of Labor must implement an emergency temporary standard to protect employees from workplace exposures to the virus that causes COVID-19 that specifically addresses pregnant and postpartum individuals. Certain regulatory requirements shall not apply in developing this standard.

The CDC must also carry out an education campaign about pregnancy and COVID-19 and must establish a task force that addresses maternity care during the COVID-19 emergency.

Furthermore, the Government Accountability Office must report on maternal health and public health emergency preparedness.

","legislationIdentifier":"HR 8027","legislationType":"Bill","legislationLegalForce":"NotInForce","legislationJurisdiction":"USA","author":[{"@type":"Person","name":"Lauren Underwood","url":"https://legisdaily.com/mp/lauren-underwood-us"}],"about":{"@type":"Thing","name":"Health"},"keywords":"Advisory bodies, Blood and blood diseases, Cardiovascular and respiratory health, Child health, Community life and organization, Congressional oversight, Department of Health and Human Services, Disability and health-based discrimination, Drug safety, medical device, and laboratory regulation, Emergency medical services and trauma care, Executive agency funding and structure, Foreign language and bilingual programs, Government information and archives, Government studies and investigations, Health facilities and institutions, Health information and medical records, Health programs administration and funding, Health promotion and preventive care, Hospital care, Immunology and vaccination, Indian social and development programs, Infectious and parasitic diseases, Licensing and registrations, Medical research, Medical tests and diagnostic methods, Mental health, Minority health, Racial and ethnic relations, Research administration and funding, Women's health","dateModified":"2025-06-03T00:00:00.000Z","url":"https://legisdaily.com/bill/USA-116-HR-8027"}

Lauren Underwood

Lauren Underwood

Indian and Insular Affairs Subcommittee, Energy and Commerce Committee, Education and Workforce Committee, Natural Resources Committee